Related Experiment Video
Updated: Jun 12, 2026

Large Scale Non-targeted Metabolomic Profiling of Serum by Ultra Performance Liquid Chromatography-Mass Spectrometry UPLC-MS
Published on: March 14, 2013
An Analytical Strategy for Reliable Metabolome Analysis of Clinical Leftover Sera Using Timed Aliquoting
Deying Chen1, Shuang Zhao2, Guanghua Ma1
1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China.
Abstract:
Accurate metabolome analysis depends not only on advanced analytical techniques but also on strict control of preanalytical variables. This study presents an analytical strategy for reliable untargeted metabolomics using clinical leftover sera, focusing on the impact of timed aliquoting during short-term storage. Leftover serum samples from routine clinical testing, typically stored at 4 °C for up to 7 days, offer a valuable and accessible resource for biomarker discovery. However, variable delays in sample aliquoting and storage can compromise metabolite stability. We used high-coverage 12C-/13C-dansylation LC-MS to profile the amine/phenol submetabolome in serum samples collected from healthy individuals at multiple time points postdraw. The study included 630 LC-MS runs (105 subjects × 6 time points) in the discovery set and 280 runs (70 subjects × 4 time points) in the validation set, quantifying 1382 and 1352 metabolites, respectively. Although time-dependent changes in metabolite abundances were observed, these shifts were relatively small between adjacent time points. Notably, clear sex-based metabolic separation was observed when using samples aliquoted at the same time or within 24-h intervals, whereas discriminatory power diminished when samples with longer storage time differences were combined. These findings demonstrate that, with carefully timed aliquoting, clinical leftover sera can be reliably used for metabolomics. Our study establishes a practical and scalable workflow to control preanalytical variation─specifically by minimizing storage time differences─thereby enabling broader use of clinical samples in biomarker discovery and population-scale metabolomics.
Related Concept Videos
Measurement of Bioavailability: Pharmacokinetic Methods
Therapeutic Drug Monitoring: Drug Analysis Methods

